Cargando…
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors
[Image: see text] To identify new chemical series with enhanced binding affinity to the BTB domain of B-cell lymphoma 6 protein, we targeted a subpocket adjacent to Val18. With no opportunities for strong polar interactions, we focused on attaining close shape complementarity by ring fusion onto our...
Autores principales: | Davis, Owen A., Cheung, Kwai-Ming J., Brennan, Alfie, Lloyd, Matthew G., Rodrigues, Matthew J., Pierrat, Olivier A., Collie, Gavin W., Le Bihan, Yann-Vaï, Huckvale, Rosemary, Harnden, Alice C., Varela, Ana, Bright, Michael D., Eve, Paul, Hayes, Angela, Henley, Alan T., Carter, Michael D., McAndrew, P. Craig, Talbot, Rachel, Burke, Rosemary, van Montfort, Rob L. M., Raynaud, Florence I., Rossanese, Olivia W., Meniconi, Mirco, Bellenie, Benjamin R., Hoelder, Swen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234963/ https://www.ncbi.nlm.nih.gov/pubmed/35657291 http://dx.doi.org/10.1021/acs.jmedchem.1c02174 |
Ejemplares similares
-
Discovery of an In Vivo Chemical
Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones
por: Harnden, Alice C., et al.
Publicado: (2023) -
Into Deep Water:
Optimizing BCL6 Inhibitors by Growing
into a Solvated Pocket
por: Lloyd, Matthew G., et al.
Publicado: (2021) -
Improved Binding
Affinity and Pharmacokinetics Enable
Sustained Degradation of BCL6 In Vivo
por: Huckvale, Rosemary, et al.
Publicado: (2022) -
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays
por: Pierrat, Olivier A., et al.
Publicado: (2022) -
Achieving In Vivo Target Depletion
through the Discovery and Optimization of Benzimidazolone BCL6 Degraders
por: Bellenie, Benjamin R., et al.
Publicado: (2020)